About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...
Millions of Americans would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare and ...
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
If the proposal is finalized, it could set the stage for a showdown between the pharmaceutical industry and the Trump ...
The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...
The Biden administration proposed a rule to let Medicare and Medicaid cover obesity drugs like Ozempic. Millions would ...
More than 200,000 prescriptions for copies of Novo Nordisk's weight-loss drug Wegovy are getting filled by U.S. patients each ...
The guidelines are part of a national trend by municipal governments and private firms struggling to manage ballooning costs ...
Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...
The diabetes drug, Ozempic, has been in the headlines, causing quite a stir. Senior writer for Drugwatch.com, Terry Turner, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback